Switch theme
Sign up to access all valuation multiples
Clariane SE operates nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. The company's nursing homes offer long-term care and medical support for elderly people. Its operating segments are: France, Germany, Benelux, Italy, and Spain & United Kingdom. The majority of its revenue is generated in France.
2003
63.1K+
LTM Revenue $6.1B
LTM EBITDA $1.2B
$10.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clariane has a last 12-month revenue (LTM) of $6.1B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Clariane achieved revenue of $6.0B and an EBITDA of $1.2B.
Clariane expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clariane valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1B | XXX | $6.0B | XXX | XXX | XXX |
| Gross Profit | $6.1B | XXX | $5.5B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 92% | XXX | XXX | XXX |
| EBITDA | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $385M | XXX | $327M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $19.4M | XXX | -$62.7M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | -1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $3.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of June 27, 2025, Clariane's stock price is EUR 5 (or $6).
Clariane has current market cap of EUR 1.8B (or $2.0B), and EV of EUR 9.3B (or $10.5B).
See Clariane trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.5B | $2.0B | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of June 27, 2025, Clariane has market cap of $2.0B and EV of $10.5B.
Clariane's trades at 1.8x EV/Revenue multiple, and 8.7x EV/EBITDA.
Equity research analysts estimate Clariane's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clariane has a P/E ratio of 105.8x.
See valuation multiples for Clariane and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV (current) | $10.5B | XXX | $10.5B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.5x | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBIT | 27.4x | XXX | 32.2x | XXX | XXX | XXX |
| EV/Gross Profit | 1.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 105.8x | XXX | -32.6x | XXX | XXX | XXX |
| EV/FCF | 17.8x | XXX | 15.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClariane's last 12 month revenue growth is 4%
Clariane's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Clariane's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clariane's rule of X is 31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clariane and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 86% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clariane acquired XXX companies to date.
Last acquisition by Clariane was XXXXXXXX, XXXXX XXXXX XXXXXX . Clariane acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Clariane founded? | Clariane was founded in 2003. |
| Where is Clariane headquartered? | Clariane is headquartered in France. |
| How many employees does Clariane have? | As of today, Clariane has 63.1K+ employees. |
| Who is the CEO of Clariane? | Clariane's CEO is Ms. Sophie Boissard. |
| Is Clariane publicy listed? | Yes, Clariane is a public company listed on PAR. |
| What is the stock symbol of Clariane? | Clariane trades under CLARI ticker. |
| When did Clariane go public? | Clariane went public in 2006. |
| Who are competitors of Clariane? | Similar companies to Clariane include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Clariane? | Clariane's current market cap is $2.0B |
| What is the current revenue of Clariane? | Clariane's last 12 months revenue is $6.1B. |
| What is the current revenue growth of Clariane? | Clariane revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Clariane? | Current revenue multiple of Clariane is 1.7x. |
| Is Clariane profitable? | Yes, Clariane is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Clariane? | Clariane's last 12 months EBITDA is $1.2B. |
| What is Clariane's EBITDA margin? | Clariane's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Clariane? | Current EBITDA multiple of Clariane is 8.5x. |
| What is the current FCF of Clariane? | Clariane's last 12 months FCF is $592M. |
| What is Clariane's FCF margin? | Clariane's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Clariane? | Current FCF multiple of Clariane is 17.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
